Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi Boss Reassures Investors and Genzyme Staff
WSJ Online
Wednesday, February 16, 2011 - 11:23am
tags:
Genzyme, Sanofi, M&A
Genzyme Buy Is Sanofi’s Bid For Stability
Forbes
Wednesday, February 16, 2011 - 11:22am
tags:
Genzyme, Sanofi, M&A
Genzyme’s Q4 profit skyrockets
Bizjournals.com
Wednesday, February 16, 2011 - 11:21am
tags:
earnings, Genzyme
Eli Lilly: Plenty of Talk, Now Time for Results
Seeking Alpha
Wednesday, February 16, 2011 - 9:44am
tags:
Eli Lilly
Novo Nordisk receives US subpoena over marketing of diabetes drugs
Yahoo/AP
Wednesday, February 16, 2011 - 9:38am
tags:
Novo Nordisk, diabetes
Depomed Hits Another Bump
Minyanville
Wednesday, February 16, 2011 - 9:37am
tags:
Depomed, Gralise, Abbott Laboratories
Sanofi-Aventis to buy Genzyme for $20.1 bln
Marketwatch
Wednesday, February 16, 2011 - 9:12am
tags:
M&A, Sanofi, Genzyme
GSK drug may slow growth of early prostate cancer
Yahoo/AP
Wednesday, February 16, 2011 - 9:11am
tags:
GSK, prostate cancer, Pfizer, Proscar, Avodart
Clinical Data Shares Popped: What You Need to Know
Motley Fool
Wednesday, February 16, 2011 - 9:09am
tags:
Clinical Data
Sanofi's Buy of Genzyme Imminent: Report
TheStreet.com
Tuesday, February 15, 2011 - 2:11pm
tags:
M&A, Sanofi, Genzyme
Ligand Pharma posts smaller 4Q profit
Yahoo/AP
Tuesday, February 15, 2011 - 2:11pm
tags:
earnings, Ligand
Analysts: Pfizer's Research Cuts Should Help Boost Stock Price
Seeking Alpha
Tuesday, February 15, 2011 - 2:04pm
tags:
R&D, Pfizer
Dealmakers: 2011 should see surge of new M&A pacts
Fierce Biotech
Tuesday, February 15, 2011 - 11:57am
tags:
M&A
AdventRx: Safe Biotech With Upcoming Catalysts That May Boost It More
Seeking Alpha
Tuesday, February 15, 2011 - 11:55am
tags:
Adventrx, Exelbine, non-small cell lung cancer
United Therapeutics turns 4Q profit as sales grow
Yahoo/AP
Tuesday, February 15, 2011 - 11:54am
tags:
earnings, United Therapeutics
Takeda Enters Into Global Strategic Partnerships With Covance and Quintiles
PR Newswire
Tuesday, February 15, 2011 - 10:48am
tags:
CROs, Takeda, Quintiles, Covance
Who will blink in Genzyme, Sanofi price talks?
Reuters
Tuesday, February 15, 2011 - 10:45am
tags:
Genzyme, Sanofi, M&A
Obama budget aims to speed generics to market
Fierce Pharma
Tuesday, February 15, 2011 - 10:43am
tags:
Obama, generics
BIO CEO Conference Live Blog: Day 2
TheStreet.com
Tuesday, February 15, 2011 - 10:25am
tags:
BIO CEO Conference
Dendreon, Teva: Benefit by Riding George Soros's Coattails
Seeking Alpha
Tuesday, February 15, 2011 - 10:24am
tags:
Teva Pharmaceuticals, Dendreon, George Soros

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.